Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline

Stock Information for InMed Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InMed Pharmaceuticals Inc.

Are ESI, INM, HUN, OLN Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--NIMU, INM, OLN, and HUN
Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-TMHC, NCSM, XOMA, and INM
Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC is Investigating Whether RAMP, NEE, INM, D are Obtaining Fair Deals for their Shareholders
The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning The Merger-RAMP, NEE, D, and INM
Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders?

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.